Ask Warren

Genexine

095700 · KOSDAQ · ₩095700 · 제넥신

₩2,160▼ ₩5 (0.23%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩972M₩415M₩537M₩3B₩672M₩320M₩306M₩209M
Cost of sales₩1.9B₩1.6B₩1.6B₩1.1B₩1.4B₩871M₩661M₩639M
Gross profit−₩967M−₩1.1B−₩1B₩1.9B−₩702M−₩552M−₩355M−₩430M
Operating income−₩10B−₩9B−₩13B−₩7.4B−₩7.5B−₩8.5B−₩7.6B−₩10B
Net income−₩26B−₩12B−₩15B₩21B−₩15B−₩19B−₩26B−₩15B
Net income to shareholders−₩26B−₩12B−₩15B₩21B−₩15B−₩19B−₩26B−₩15B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩332B₩355B₩371B₩366B₩333B₩338B₩345B₩341B
Current assets₩34B₩35B₩46B₩38B₩46B₩48B₩47B₩54B
Cash and equivalents₩10B₩3.8B₩9.2B₩9.6B₩7B₩6.9B₩1.2B₩2.4B
Total liabilities₩132B₩126B₩125B₩106B₩99B₩95B₩83B₩82B
Current liabilities₩126B₩119B₩117B₩66B₩61B₩64B₩54B₩55B
Borrowings₩115B₩104B₩108B₩95B₩91B₩85B₩76B₩72B
Total equity₩200B₩230B₩247B₩260B₩234B₩243B₩262B₩259B
Shareholders' equity₩200B₩230B₩247B₩260B₩234B₩243B₩262B₩259B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩11B−₩3.1B−₩11B−₩3B−₩16B₩800M₩11B−₩7.6B
Capital spending−₩85M₩5.2B₩2.4B₩5.1B₩3.4B₩3.9B₩2B₩2.1B
Free cash flow−₩11B−₩8.3B−₩14B−₩8B−₩20B−₩3.1B₩8.6B−₩9.6B

Consolidated where available. Amounts in won.

Also known as: Genexine / 제넥신 / 095700 / KRX:095700

Source: KRX statistical information